EUVIMEDEUVIMED entdecken
Open Access

Anti-Annexin V Antibodies: Association with Vascular Involvement and Disease Outcome in Patients with Systemic Sclerosis

Reem A Habeeb, Howaida E Mansour, Aya M Abdeldayem, Rania A Abo-Shady, Iman A Hassan, Nazek K Saafan, Dalia G Aly

Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders · 2010-01 · 3 · CMAMD.S4503

DOI: 10.4137/cmamd.s4503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, online erschienen am 28.04.2010. Verfasst von Reem A Habeeb und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Internal Medicine. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Systemic Sclerosis (SSc) is characterized by skin thickening, fibrosis and vascular obliteration. The onset and course are heterogeneous. Prominent features include autoimmunity, inflammation and vascular damage. Aim of Study To measure the level of serum Anti-Annexin V antibodies in SSc patients and to study its significance in relation to vascular damage in these patients. Patients and Methods Twenty patients with SSc (12 with diffuse SSc and 8 with the limited form) and 10 healthy age and sex matched volunteers as controls were all subjected to routine laboratory testing and immunological profiling including antinuclear, anti-Scl-70, anticentomere, anticardiolipin antibodies and anti-annexin V antibodies titres. Vascular damage was assessed by clinical examination and assessment of the disease activity score, nailfold capillaroscopy and colour flow Doppler of the renal arteries; Doppler echocardiography was used for assessing pulmonary hypertension.

Results

Anti-annexin V antibodies were detected in 75% of patients. Comparisons between anti-annexin V in diffuse and limited subgroups showed no significance; however a statistically significant positive correlation was found between Anti-annexin V titre and the degree of vascular damage in SSc patients. Anti-annexin V increased significantly in patients with severe vascular damage in comparison with those less affected (15.3 ± 6.6 vs. 11.25 ± 3.6, P < 0.05). A significant positive correlation was found between Anti-annexin V titre and both the ACL titre (r = 0.79, P < 0.001) and the resistive index of the main renal artery (r = 0.42, P < 0.05).

Conclusion

Anti-annexin V antibodies were significantly present in sera of patients with SSc. Patients with more severe forms of vascular damage had higher titres of these antibodies. Anti-annexin V antibodies are a sensitive predictor of vascular damage in SSc and could serve as a useful parameter in discriminating patients with a higher risk of vascular affection from those without.

Schlagwörter

Stichwörter der Autor:innen

anti-annexin V antibodiessystemic sclerosisvascular damage

Autor:innen und Institutionen

  • Departments of Internal Medicine.

Zitieren

APA

Habeeb, R. A., Mansour, H. E., Abdeldayem, A. M., Abo-Shady, R. A., Hassan, I. A., Saafan, N. K., & Aly, D. G. (2010). Anti-Annexin V Antibodies: Association with Vascular Involvement and Disease Outcome in Patients with Systemic Sclerosis. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, 3, CMAMD.S4503. https://doi.org/10.4137/cmamd.s4503

Vancouver

Habeeb RA, Mansour HE, Abdeldayem AM, Abo-Shady RA, Hassan IA, Saafan NK, et al. Anti-Annexin V Antibodies: Association with Vascular Involvement and Disease Outcome in Patients with Systemic Sclerosis. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders. 2010;3:CMAMD.S4503. doi:10.4137/cmamd.s4503

BibTeX
@article{Habeeb2010,
  author = {Habeeb, Reem A and Mansour, Howaida E and Abdeldayem, Aya M and Abo-Shady, Rania A and Hassan, Iman A and Saafan, Nazek K and Aly, Dalia G},
  title = {Anti-Annexin V Antibodies: Association with Vascular Involvement and Disease Outcome in Patients with Systemic Sclerosis},
  journal = {Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders},
  year = {2010},
  volume = {3},
  pages = {CMAMD.S4503},
  doi = {10.4137/cmamd.s4503}
}
Kostenlos starten →